Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02632721
Title A Study to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | ESP | DEU


No variant requirements are available.